Pirlich M, Schütz T, Spachos T, Ertl S, Weiss M L, Lochs H, Plauth M
Medizinische Klinik und Poliklinik, Abteilung Gastroenterologie, Universitätsklinikum Charité, Berlin, Germany.
Hepatology. 2000 Dec;32(6):1208-15. doi: 10.1053/jhep.2000.20524.
Protein-calorie malnutrition is associated with poor prognosis in chronic liver disease, but reliable assessment is hampered by changes in body water. We prospectively evaluated the effect of fluid retention on bioelectrical impedance analysis (BIA) as a simple method for the estimation of body cell mass (BCM(BIA)) in 41 patients with cirrhosis (n = 20 with ascites; n = 21 without ascites) using total body potassium counting (BCM(TBP)) as a reference method. Arm muscle area and creatinine-derived lean body mass were compared with total body potassium data. In patients total body potassium was 24.4% lower than in controls and this loss was more severe in patients with ascites (-34.1%; P<.01). BCM(BIA) and BCM(TBP) were closely correlated in controls (r(2) =.87, P<.0001), patients without ascites (r(2) =.94, P <.0001) and patients with ascites (r(2) =.56, P<.0001). Removal of 6.2 +/- 3 L of ascites had only minor effects on BCM(BIA) (deviation of -0.18 kg/L ascites). Limits of agreement between both methods were wider in patients with ascites than in patients without (6.2 vs. 4.2 kg). In patients without ascites arm muscle area (r(2) =.64; P<.001) and lean body mass (r(2) =.55; P<.001) correlated significantly with total body potassium, but not in patients with ascites. For assessment of protein malnutrition in patients with cirrhosis, body cell mass determination by use of BIA offers a considerable advantage over other widely available but less accurate methods like anthropometry or the creatinine approach. Despite some limitations in patients with ascites, BIA is a reliable bedside tool for the determination of body cell mass in cirrhotic patients with and without ascites.
蛋白质 - 热量营养不良与慢性肝病的不良预后相关,但由于身体水分的变化,可靠的评估受到阻碍。我们前瞻性地评估了液体潴留对生物电阻抗分析(BIA)的影响,BIA是一种用于估计身体细胞质量(BCM(BIA))的简单方法,以全身钾计数(BCM(TBP))作为参考方法,对41例肝硬化患者(20例有腹水;21例无腹水)进行了研究。将手臂肌肉面积和肌酐衍生的瘦体重与全身钾数据进行比较。患者的全身钾比对照组低24.4%,且这种损失在有腹水的患者中更严重(-34.1%;P<.01)。BCM(BIA)和BCM(TBP)在对照组(r(2) =.87,P<.0001)、无腹水患者(r(2) =.94,P <.0001)和有腹水患者(r(2) =.56,P<.0001)中密切相关。抽取6.2±3 L腹水对BCM(BIA)仅有轻微影响(每升腹水偏差-0.18 kg)。两种方法之间的一致性界限在有腹水的患者中比无腹水的患者更宽(6.2 vs. 4.2 kg)。在无腹水的患者中,手臂肌肉面积(r(2) =.64;P<.001)和瘦体重(r(2) =.55;P<.001)与全身钾显著相关,但在有腹水的患者中则不然。对于肝硬化患者蛋白质营养不良的评估,使用BIA测定身体细胞质量比其他广泛使用但不太准确的方法(如人体测量法或肌酐法)具有相当大的优势。尽管在有腹水的患者中存在一些局限性,但BIA是一种用于确定有腹水和无腹水肝硬化患者身体细胞质量的可靠床边工具。